Robert A. Bradway - 30 Apr 2025 Form 4 Insider Report for AMGEN INC (AMGN)

Role: Chairman, CEO and President, Director
Signature: /s/ Robert A. Bradway
Issuer symbol: AMGN
Transactions as of: 30 Apr 2025
Transactions value $: -$734,097
Form type: 4
Filing time: 02 May 2025, 21:23:28 UTC
Previous filing: 03 Apr 2025
Next filing: 06 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Bradway Robert A	Chairman, CEO and President, Director	ONE AMGEN CENTER DRIVE, THOUSAND OAKS	/s/ Robert A. Bradway	30 Apr 2025	0001396482

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMGN	Common Stock	Tax liability	-$734K	-2.54K	-0.62%	$288.56	405K	30 Apr 2025	Direct	F1
holding	AMGN	Common Stock						90K	30 Apr 2025	By GRAT
holding	AMGN	Common Stock						90K	30 Apr 2025	By Spousal GRAT

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares include 2,169 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Content

These shares include 2,169 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.